Evidence map›Paper›PMID 26965125›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2016

Combined Optogenetic and Chemogenetic Control of Neurons.

Ken Berglund, Jack K Tung, Bryan Higashikubo, Robert E Gross, Christopher I Moore, Ute Hochgeschwender

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ken BerglundDepartment of Neurosurgery, Emory University, Atlanta, GA, USA.
Jack K TungDepartment of Neurosurgery, Emory University, Atlanta, GA, USA.
Bryan HigashikuboDepartment of Neuroscience, Brown University, Providence, RI, USA.
Robert E GrossDepartment of Neurosurgery, Emory University, Atlanta, GA, USA.
Christopher I MooreDepartment of Neuroscience, Brown University, Providence, RI, USA.
Ute HochgeschwenderNeuroscience Program and College of Medicine, Central Michigan University, 1280 S. East Campus Drive, CMED 1432, Mt. Pleasant, MI, USA. ute.hochgeschwender@cmich.edu.
Emory University · USBrown University · USCentral Michigan University · US

Funding

Autonomous Optogenetic Inhibition of Epileptic Activity Using a Bioluminescent LiR01NS079268 · NINDS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 2012 to 2015
$1.4M
Employing subcellular calcium to control membrane voltageR21EY026427 · NEI · CENTRAL MICHIGAN UNIVERSITY · PI HOCHGESCHWENDER, UTE H, LIPSCOMBE, DIANE · 2015 to 2016
$472k
Genetically Encoded Light-Production and Light-Sensing for Neuronal ManipulationR21MH101525 · NIMH · DUKE UNIVERSITY · PI HOCHGESCHWENDER, UTE H · 2013 to 2015
$434k
An Autonomous Biologic Controller for Optogenetic ApplicationsF31NS086433 · NINDS · GEORGIA INSTITUTE OF TECHNOLOGY · PI TUNG, JACK · 2013 to 2015
$85k
NEI NIH HHS R21 EY026427NIMH NIH HHS MH101525NIMH NIH HHS R21 MH101525NINDS NIH HHS F31 NS086433NINDS NIH HHS NS079268NINDS NIH HHS NS086433NINDS NIH HHS R01 NS079268
6 · The paper itself

Abstract

Optogenetics provides an array of elements for specific biophysical control, while designer chemogenetic receptors provide a minimally invasive method to control circuits in vivo by peripheral injection. We developed a strategy for selective regulation of activity in specific cells that integrates opto- and chemogenetic approaches, and thus allows manipulation of neuronal activity over a range of spatial and temporal scales in the same experimental animal. Light-sensing molecules (opsins) are activated by biologically produced light through luciferases upon peripheral injection of a small molecule substrate. Such luminescent opsins, luminopsins, allow conventional fiber optic use of optogenetic sensors, while at the same time providing chemogenetic access to the same sensors. We describe applications of this approach in cultured neurons in vitro, in brain slices ex vivo, and in awake and anesthetized animals in vivo.

Indexed as

AnimalsBrainCell Culture TechniquesCells, CulturedElectrodesElectrophysiological PhenomenaFiber Optic TechnologyHEK293 CellsHumansLightLuciferasesLuminescenceLuminescent AgentsLuminescent MeasurementsNeuronsOpsinsLuciferasesLuminescent AgentsOpsinsBehaviorBioluminescenceChemogeneticsCoelenterazineElectrophysiologyLuciferaseLuminopsinMultielectrode arrayNeuronOptogenetics

Identifiers

PMID26965125
PMCPMC5149414
OpenAlexW2418252845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.